Please see new guidance from the UK Chemotherapy Board on ‘Personalised Medicine Approach For Fluoropyrimidine-based Therapies’.
Objective of document: To provide clinical staff with guidance as to which patients should receive a DPD test and then subsequently to provide advice to clinical staff on the outcome of that test.
Full guidance can be accessed HERE or found in our resource center in the BOPA website.
When: Monday 6 July 1-2pm GMT Consensus methods can be applied to co-production of new approaches to care, services or guidelines in areas less researched such as supportive care. The…
BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those…
We’re excited to share some news about BOPA’s visual identity and digital home — two projects that reflect our commitment to keeping the association relevant, modern, and genuinely useful for…
Are you working towards more sustainable cancer care? Hosted by the Centre for Sustainable Healthcare, the Cancer Care Sustainability Network is a free online network bringing together healthcare professionals, researchers,…
The 29th BOPA Annual Conference in 2026 will be held at the ICC London Olympia on 2-4 October 2026.
Check out the latest information here: Latest Conference 2026 – BOPA
Everything you need to know
